Erasca, Inc.

NASDAQ:ERAS

Biotechnology

Healthcare
$13.76 -0.14%

-$0.02 today

Market cap
$4.83B
Beta
0.73
P/E (TTM)
-15.3
EPS (TTM)
-$0.91
52W Low $1.21High $24.28

Volume 8.94M

Average 6.79M

Price history

Erasca, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+381.12%

Period high

$22.47

Period low

$2.76

Latest

$13.76

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
8-KOct 16, 2026Oct 16, 2026
8-KAug 24, 2026Aug 24, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
3Aug 12, 2026Aug 12, 2026
4Aug 12, 2026Aug 12, 2026
10-QAug 11, 2026Aug 11, 2026
S-8Aug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
8-KAug 10, 2026Aug 10, 2026
424B5Jul 14, 2026Jul 14, 2026
8-KJul 14, 2026Jul 14, 2026
8-KJul 13, 2026Jul 13, 2026
S-3ASRJul 13, 2026Jul 13, 2026

Competitors

Who does Erasca, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ERAS's filings, answered from its disclosures.

What is the latest ERAS filing?

The latest filing shown is 10-Q dated Nov 12, 2026.

How many recent filings does ERAS have?

Intrinsic Alpha currently shows 20 recent filings for ERAS.